Todd Asset Management LLC Increases Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Todd Asset Management LLC increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 319,260 shares of the company's stock after buying an additional 5,173 shares during the period. Todd Asset Management LLC owned about 0.07% of GE HealthCare Technologies worth $24,960,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the business. Allspring Global Investments Holdings LLC raised its position in GE HealthCare Technologies by 2.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company's stock valued at $2,317,000 after purchasing an additional 562 shares in the last quarter. International Assets Investment Management LLC increased its stake in shares of GE HealthCare Technologies by 10,227.3% during the third quarter. International Assets Investment Management LLC now owns 621,913 shares of the company's stock worth $58,367,000 after buying an additional 615,891 shares during the period. Assenagon Asset Management S.A. raised its holdings in GE HealthCare Technologies by 10.1% in the third quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company's stock valued at $1,289,000 after acquiring an additional 1,256 shares in the last quarter. Dakota Wealth Management purchased a new position in GE HealthCare Technologies in the third quarter worth approximately $210,000. Finally, Lake Street Advisors Group LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $239,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded down $2.05 during trading on Friday, reaching $87.35. The company's stock had a trading volume of 4,214,406 shares, compared to its average volume of 2,887,457. The company has a 50-day moving average price of $86.00 and a two-hundred day moving average price of $86.07. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The firm has a market cap of $39.94 billion, a PE ratio of 20.17, a P/E/G ratio of 3.19 and a beta of 1.15. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on GEHC. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup lifted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and an average price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.